OBJECTIVE: To estimate direct and indirect economic costs among private-sector employees with osteoarthritis (OA). METHODS: Using a large US employer benefits database, we identified all employees with evidence of OA during calendar year 2007, and compared their costs of health care and work loss to age-and-sex-matched employees without evidence of OA in that year. RESULTS: Private-sector employees with OA (n = 2399) averaged 62.9 days of absenteeism versus 36.7 days among matched comparators (n = 2399) (P < 0.01). Mean total direct costs among these persons were $17,751 and $5057, respectively (P < 0.01); 34% of health care costs among persons with OA arose from medical encounters with listed diagnoses of OA. Mean total indirect costs were two-fold higher among persons with OA ($5002 versus $2120 for those without OA; P < 0.01). CONCLUSIONS: Private-sector employees with OA have higher direct and indirect costs than those without this condition.
OBJECTIVE: To estimate direct and indirect economic costs among private-sector employees with osteoarthritis (OA). METHODS: Using a large US employer benefits database, we identified all employees with evidence of OA during calendar year 2007, and compared their costs of health care and work loss to age-and-sex-matched employees without evidence of OA in that year. RESULTS: Private-sector employees with OA (n = 2399) averaged 62.9 days of absenteeism versus 36.7 days among matched comparators (n = 2399) (P < 0.01). Mean total direct costs among these persons were $17,751 and $5057, respectively (P < 0.01); 34% of health care costs among persons with OA arose from medical encounters with listed diagnoses of OA. Mean total indirect costs were two-fold higher among persons with OA ($5002 versus $2120 for those without OA; P < 0.01). CONCLUSIONS: Private-sector employees with OA have higher direct and indirect costs than those without this condition.
Authors: Elena Losina; A David Paltiel; Alexander M Weinstein; Edward Yelin; David J Hunter; Stephanie P Chen; Kristina Klara; Lisa G Suter; Daniel H Solomon; Sara A Burbine; Rochelle P Walensky; Jeffrey N Katz Journal: Arthritis Care Res (Hoboken) Date: 2015-02 Impact factor: 4.794
Authors: Elena Losina; Karen C Smith; A David Paltiel; Jamie E Collins; Lisa G Suter; David J Hunter; Jeffrey N Katz; Stephen P Messier Journal: Arthritis Care Res (Hoboken) Date: 2019-07 Impact factor: 4.794
Authors: F R Nelson; R A Zvirbulis; B Zonca; K W Li; S M Turner; M Pasierb; P Wilton; D Martinez-Puig; W Wu Journal: Rheumatol Int Date: 2014-06-05 Impact factor: 2.631
Authors: Leah L Zullig; Hayden B Bosworth; Amy S Jeffreys; Leonor Corsino; Cynthia J Coffman; Eugene Z Oddone; William S Yancy; Kelli D Allen Journal: Clin Rheumatol Date: 2014-06-12 Impact factor: 2.980
Authors: Kelli D Allen; Hayden B Bosworth; Dorothea S Brock; Jennifer G Chapman; Ranee Chatterjee; Cynthia J Coffman; Santanu K Datta; Rowena J Dolor; Amy S Jeffreys; Karen A Juntilla; Jennifer Kruszewski; Laurie E Marbrey; Jennifer McDuffie; Eugene Z Oddone; Nina Sperber; Mary P Sochacki; Catherine Stanwyck; Jennifer L Strauss; William S Yancy Journal: BMC Musculoskelet Disord Date: 2012-04-24 Impact factor: 2.362
Authors: Angela V Bedenbaugh; Machaon Bonafede; Elizabeth H Marchlewicz; Vinson Lee; Jeyanesh Tambiah Journal: Clinicoecon Outcomes Res Date: 2021-05-21